News
Free RSV vaccination for Qld pregnant women
Queensland’s expectant mothers are now eligible for a subsidised Abrysvo vaccination, as the state’s RSV cases soar to 40,000 in 2024.
Across Australia, 169,740 cases of RSV have been recorded so far in 2024.
In a bid to combat its skyrocketing respiratory syncytial virus (RSV) case numbers, the Queensland Government has announced a $13.5 million expansion of its free vaccination program.
As of 1 December, the expanded program will offer pregnant mothers a subsidised Abrysvo immunisation, which can be administered between 28 and 36 weeks of pregnancy.
Free access to the monoclonal antibody, nirsevimab (sold as Beyfortus) is already available for the state’s newborn babies, eligible infants and young children.
So far in 2024, 39,994 cases of RSV have been recorded in Queensland, up from 28,791 the year before.
Nationwide, 169,740 cases have been recorded in 2024, with about 42% of those being in New South Wales.
Queensland Chief Health Officer Dr John Gerrard said the results of the RSV paediatric immunisation program were already being seen among infant hospitalisation rates.
‘As of 24 November this year, we recorded 372 fewer hospitalisations among babies aged under six months this year compared to the same time last year,’ he said.
‘We know we can do better and that’s why expanding the program is great news.
‘This immunisation program is expected to continue alleviating pressure on paediatric healthcare services across Queensland.’
Dr Gerrard said it is estimated the expanded RSV immunisation program will prevent around 960 hospitalisations among Queensland children next year during their first six months.
Queensland’s expansion follows a Federal Government announcement earlier this month that the Abrysvo vaccine would be added to the National Immunisation Program.
However, the state’s program will roll out in advance of the national program, which will begin before winter 2025.
Queensland Health Minister Tim Nicholls said almost all Queensland children ‘will experience at least one RSV infection by the time they turn two’.
‘The vaccine can reduce severe disease and decrease hospitalisation rates,’ he said.
‘It is an invaluable addition to the state’s immunisation program to support the health of young Queenslanders.’
Log in below to join the conversation.
Abrysvo respiratory syncytial virus RSV vaccination
newsGP weekly poll
Do you support patients registered with MyMedicare having access to MBS rebates if they have not met the 12-month relationship rule?